President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

Emphasizes that the United States aims to provide access to prescription drugs at lower costs for US patients and taxpayers, ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

If prescription savings are to be passed on to Americans not on Medicare, Congress likely would have to pass a law to enact ...

For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...

More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

Toward the end of his first Administration, Trump signed a similar Executive Order aimed at lowering the prices of some drugs ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...